Endo Health Solutions Inc. reaffirms 2012 adjusted diluted EPS to be at or below low end of previous range of $5.00-$5.10. Company expects asset impairment and other charges to materially reduce reported diluted (GAAP) EPS in 2012 to amounts materially below previously announced guidance of $0.87 to $0.97.

The company also provided its current outlook for non-GAAP financial performance for the year ending December 31, 2013 as total revenue between $2.80 billion and $2.95 billion and adjusted diluted earnings per share between $4.40 and $4.70. Its estimates are based on projected results for the year ended December 31, 2013. In addition, its 2013 guidance is based on certain assumptions including adjusted gross margin between 64% and 66%. Adjusted effective tax rate was between 28.5% and 29.5%. Capital expenditures were approximately $120 million.